Premium
GBE attenuates arsenite‐induced hepatotoxicity by regulating E2F1‐autophagy‐E2F7a pathway and restoring lysosomal activity
Author(s) -
Chen Xiong,
Wang Dapeng,
Sun Baofei,
Liu Chunyan,
Zhu Kai,
Zhang Aihua
Publication year - 2021
Publication title -
journal of cellular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 174
eISSN - 1097-4652
pISSN - 0021-9541
DOI - 10.1002/jcp.30147
Subject(s) - autophagy , autophagosome , microbiology and biotechnology , programmed cell death , pi3k/akt/mtor pathway , tfeb , chemistry , lysosome , biology , apoptosis , signal transduction , biochemistry , enzyme
Arsenic is an environmental toxicant. Its overdose can cause liver damage. Autophagy has been reported to be involved in arsenite (iAs 3+ ) cytotoxicity and plays a dual role in cell proliferation and cell death. However, the effect and molecular regulative mechanisms of iAs 3+ on autophagy in hepatocytes remains largely unknown. Here, we found that iAs 3+ exposure lead to hepatotoxicity by inducing autophagosome and autolysosome accumulation. On the one hand, iAs 3+ promoted autophagosome synthesis by inhibiting E2F1/mTOR pathway in L‐02 human hepatocytes. On the other, iAs 3+ blocked autophagosome degradation partially via suppressing the expression of INPP5E and Rab7 as well as impairing lysosomal activity. More importantly, autophagosome and autolysosome accumulation induced by iAs 3+ increased the protein level of E2F7a, which could further inhibit cell viability and induce apoptosis of L‐02 cells. The treatment of Ginkgo biloba extract (GBE) effectively reduced autophagosome and autolysosome accumulation and thus alleviated iAs 3+ ‐induced hepatotoxicity. Moreover, GBE could also protect lysosomal activity, promote the phosphorylation level of E2F1 (Ser364 and Thr433) and Rb (Ser780) as well as suppress the protein level of E2F7a in iAs 3+ ‐treated L‐02 cells. Taken together, our data suggested that autophagosome and autophagolysosome accumulation play a critical role for iAs 3+ ‐induced hepatotoxicity, and GBE is a promising candidate for intervening iAs 3+ induced liver damage by regulating E2F1‐autophagy‐E2F7a pathway and restoring lysosomal activity.